Skip to main content

Table 2 Individual treatment on day 0

From: Efficacy of an oral combination of afoxolaner and milbemycin oxime for the prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs

Dog

Tablet combination*

Dose (mg)

Dosage (mg/kg)

#

Body weight (kg)

Afoxolaner

MO

Afoxolaner

MO

1

15.95

9/2 + 38/8

46.875

9.375

2.94

0.59

2

21.55

19/4 + 38/8

56.250

11.250

2.61

0.52

3

18.75

19/4 + 38/8

56.250

11.250

3.00

0.60

4

18.45

9/2 + 38/8

46.875

9.375

2.54

0.51

5

19.65

19/4 + 38/8

56.250

11.250

2.86

0.57

6

14.15

38/8

37.500

7.500

2.65

0.53

7

23.80

9/2 + 19/4 + 38/8

65.625

13.125

2.76

0.55

8

14.35

38/8

37.500

7.500

2.61

0.52

    

Mean

2.75

0.55

  1. *NexGard Spectra® strengths:
  2. 9/2 = 9.375 mg afoxolaner & 1.875 mg milbemycin oxime (for dogs 2–3.5 kg)
  3. 19/4: 18.75 mg afoxolaner & 3.75 mg milbemycin oxime (for dogs > 3.5–7.5 kg)
  4. 38/8: 37.5 mg afoxolaner & 7.5 mg milbemycin oxime (for dogs > 7.5–15 kg)
Back to article page

Parasites & Vectors

ISSN: 1756-3305

Contact us